- Home
- RGR vs PRME Comparison
RGR vs PRME Comparison
Compare RGR & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGR
- PRME
- Stock Information
- Founded
- RGR 1949
- PRME 2019
- Country
- RGR United States
- PRME United States
- Employees
- RGR N/A
- PRME N/A
- Industry
- RGR Ordnance And Accessories
- PRME Medicinal Chemicals and Botanical Products
- Sector
- RGR Industrials
- PRME Health Care
- Exchange
- RGR Nasdaq
- PRME Nasdaq
- Market Cap
- RGR 553.4M
- PRME 624.0M
- IPO Year
- RGR N/A
- PRME 2022
- Fundamental
- Price
- RGR $36.89
- PRME $3.99
- Analyst Decision
- RGR
- PRME Buy
- Analyst Count
- RGR 0
- PRME 6
- Target Price
- RGR N/A
- PRME $8.88
- AVG Volume (30 Days)
- RGR 178.3K
- PRME 2.9M
- Earning Date
- RGR 10-29-2025
- PRME 11-11-2025
- Dividend Yield
- RGR 1.89%
- PRME N/A
- EPS Growth
- RGR N/A
- PRME N/A
- EPS
- RGR 0.35
- PRME N/A
- Revenue
- RGR $536,291,000.00
- PRME $4,961,000.00
- Revenue This Year
- RGR N/A
- PRME $179.58
- Revenue Next Year
- RGR $3.39
- PRME N/A
- P/E Ratio
- RGR $107.30
- PRME N/A
- Revenue Growth
- RGR 3.31
- PRME 739.42
- 52 Week Low
- RGR $31.64
- PRME $1.11
- 52 Week High
- RGR $42.76
- PRME $5.17
- Technical
- Relative Strength Index (RSI)
- RGR 65.74
- PRME 56.90
- Support Level
- RGR $34.42
- PRME $3.09
- Resistance Level
- RGR $37.39
- PRME $4.18
- Average True Range (ATR)
- RGR 0.70
- PRME 0.26
- MACD
- RGR 0.28
- PRME 0.08
- Stochastic Oscillator
- RGR 84.23
- PRME 82.11
About RGR Sturm Ruger & Company Inc.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.